RESEARCH PAPER
Gaps and solutions of HIV testing, care, and treatment in Iran during 2018-2019
1
Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran
2
Social Determinants of Health Research Center, Amir-al-Momenin Hospital, Tehran Medical Sciences Branch, Islamic Azad University, Tehran, Iran
3
HIV/AIDS Control Office, Center for Communicable Disease, Ministry of Health, Tehran, Iran
4
Center for Communicable Disease Control, Ministry of Health & Medical Education, Tehran, Iran
5
Social Determinants of Health Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran
6
HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies
in Health, Kerman University of Medical Sciences, Kerman, Iran
7
The Excellent Center for Dengue and Community Public Helath (EC for DACH), School of Public Health, Walailak University, Nakhon Si Thammarat, Thailand
Submission date: 2021-02-02
Final revision date: 2021-03-17
Acceptance date: 2021-03-17
Publication date: 2021-12-26
HIV & AIDS Review 2021;20(4):287-293
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Human immunodeficiency virus (HIV) test-treat-retain cascade analysis, is a model to identify gaps at every stage of service delivery, and formulate potential solutions to enhance coverage of these services, as we aimed to carry out in the present study.
Material and methods:
In order to detect problems, develop solutions, and further prioritize them at different stages of HIV cascade, Fishbone analysis model (WHO 2018) was used. At first, an Excel file including 15 sheets was constructed, each sheet for a significant demographic data of sub-group covering all key populations. Within each sheet, cascade diagram for diagnostic services, connection to services, treatment, and suppression of viral load was demonstrated. Excel file was sent to 28 key persons. Participants were instructed to identify problems in each stage and list all probable reasons for every specific problem. These reasons were classified into six groups based on Fishbone model, including: 1) policies/guidelines; 2) service/program management; 3) human resources; 4) supplies; 5) services delivery methods; and 6) patient/client-related factors. Subsequently, participants were instructed to propose their potential solutions to address these obstacles. Finally, four key informants prioritized the problems and suggested solutions.
Results:
Analysis of the most important solutions (with 10-12 scores) proposed by key persons of the five groups, including the increase of society awareness, addressing the stigma of HIV disease in mass media, collaboration between politics and health parties to enhance society knowledge, expanding the treatment and counseling centers and facilities across the country, healthcare workers training to provide valid and reliable guidance and information to people who live with HIV, and refer them to designated centers for care, counseling, and treatment as well as appropriate patient detection, mapping procedure, and gathering precise statistics, and finally, employment of professional caregivers in counseling and testing centers.
Conclusions:
Based on the identified gaps, innovative strategies to improve HIV testing and early case detection, particularly for key populations, are critical to reach the 90-90-90 target of the UNIAID.
Human immunodeficiency virus (HIV) test-treat-retain cascade analysis, is a model to identify gaps at every stage of service delivery, and formulate potential solutions to enhance coverage of these services, as we aimed to carry out in the present study.
Material and methods:
In order to detect problems, develop solutions, and further prioritize them at different stages of HIV cascade, Fishbone analysis model (WHO 2018) was used. At first, an Excel file including 15 sheets was constructed, each sheet for a significant demographic data of sub-group covering all key populations. Within each sheet, cascade diagram for diagnostic services, connection to services, treatment, and suppression of viral load was demonstrated. Excel file was sent to 28 key persons. Participants were instructed to identify problems in each stage and list all probable reasons for every specific problem. These reasons were classified into six groups based on Fishbone model, including: 1) policies/guidelines; 2) service/program management; 3) human resources; 4) supplies; 5) services delivery methods; and 6) patient/client-related factors. Subsequently, participants were instructed to propose their potential solutions to address these obstacles. Finally, four key informants prioritized the problems and suggested solutions.
Results:
Analysis of the most important solutions (with 10-12 scores) proposed by key persons of the five groups, including the increase of society awareness, addressing the stigma of HIV disease in mass media, collaboration between politics and health parties to enhance society knowledge, expanding the treatment and counseling centers and facilities across the country, healthcare workers training to provide valid and reliable guidance and information to people who live with HIV, and refer them to designated centers for care, counseling, and treatment as well as appropriate patient detection, mapping procedure, and gathering precise statistics, and finally, employment of professional caregivers in counseling and testing centers.
Conclusions:
Based on the identified gaps, innovative strategies to improve HIV testing and early case detection, particularly for key populations, are critical to reach the 90-90-90 target of the UNIAID.
REFERENCES (39)
2.
Consortium WTS. Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet 2009; 373: 1352-1363.
3.
Sardashti S, Samaei M, Firouzeh MM, Mirshahvalad SA, Pahlaviani FG, SeyedAlinaghi S. Early initiation of antiretroviral treatment: Challenges in the Middle East and North Africa. World J Virol 2015; 4: 134-141.
4.
Center for Communicable Diseases Control, Ministry of Health and Medical Education. Latest statistics on HIV infection in Islamic Republic of Iran, April to June 2017; 2018.
5.
Joulaei H, Motazedian N. Primary health care strategic key to control HIV/AIDS in Iran. Iran J Public Health 2013; 42: 540-541.
6.
Palella Jr FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998; 338: 853-860.
7.
Kitahata MM, Gange SJ, Abraham AG, et al. Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med 2009; 360: 1815-1826.
9.
Late diagnosis of HIV infection in the era of highly active anti retroviral therapy: consequences for AIDS incidence. AIDS 2002; 16: 1945-1951.
10.
Easterbrook PJ, Yu LM, Goetghebeur E, Boag F, McLean K, Gaz zard B. Ten-year trends in CD4 cell counts at HIV and AIDS diagnosis in a London HIV clinic. AIDS 2000; 14: 561-571.
11.
Sabin CA, Smith CJ, Gumley H, et al. Late presenters in the era of highly active antiretroviral therapy: uptake of and responses to antiretroviral therapy. AIDS 2004; 18: 2145-2151.
12.
Sudarshi D, Pao D, Murphy G, Parry J, Dean G, Fisher M. Missed opportunities for diagnosing primary HIV infection. Sex Trans Infect 2008; 84: 14-16.
13.
Bajunirwe F, Tumwebaze F, Abongomera G, Akakimpa D, Kityo C, Mugyenyi PN. Identification of gaps for implementation science in the HIV prevention, care and treatment cascade; a qualitative study in 19 districts in Uganda. BMC Res Notes 2016; 9: 217.
14.
Kay ES, Batey DS, Mugavero MJ. The HIV treatment cascade and care continuum: updates, goals, and recommendations for the future. AIDS Res Ther 2016; 13: 35.
15.
Hamers F, Devaux I, Alix J, Nardone A. HIV/AIDS in Europe: trends and EU-wide priorities. Euro Surveill 2006; 11: E061123.1.
16.
Moradi G, Mohraz M, Gouya M, et al. Problems of providing services to people affected by HIV/AIDS: service providers and recipients perspectives. East Mediterr Health J 2015; 21: 20-28.
17.
Mercier DA. A mixed methods study of perceived social support based on the medical outcomes study social support survey in adults with repeated challenges with HIV medication adherence. Columbia: University of Missouri; 2016.
18.
Mills EJ, Nachega JB, Bangsberg DR, et al. Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med 2006; 3: e438.
19.
Haas AD, Msukwa MT, Egger M, et al. Adherence to antiretroviral therapy during and after pregnancy: cohort study on women receiving care in Malawi’s option B+ program. Clin Infect Dis 2016; 63: 1227-1235.
20.
Posse M, Meheus F, Van Asten H, Van Der Ven A, Baltussen R. Barriers to access to antiretroviral treatment in developing countries: a review. Trop Med Int Health 2008; 13: 904-913.
21.
Kagee A, Remien R, Berkman A, Hoffman S, Campos L, Swartz L. Structural barriers to ART adherence in Southern Africa: challenges and potential ways forward. Global Public Health 2011; 6: 83-97.
22.
Daryazadeh S. Investigation of adherence and process of anti-retroviral therapy in patients referred to Isfahan Behavioral Consultation Center during ten years. Razi Journal of Medical Sciences 2014; 21: 62-70.
23.
Mukherjee JS, Ivers L, Leandre F, Farmer P, Behforouz H. Antiretroviral therapy in resource-poor settings: decreasing barriers to access and promoting adherence. J Acquir Immune Defic Syndr 2006; 43: S123-S126.
26.
Khalili H, Rohani R, Seyedalinaghi S, Hajiabdolbaghi M, Dashti-Khavidaki S, Talasaz AH. Adherence to antiretroviral therapy among Iranian HIV/AIDS patients. Curr Clin Pharmacol 2012; 7: 111-115.
27.
Kilmarx PH, Mutasa-Apollo T. Patching a leaky pipe: the cascade of HIV care. Curr Opin HIV AIDS 2013; 8: 59-64.
28.
Niakan S, Mehraeen E, Noori T, Gozali E. Web and mobile based HIV prevention and intervention programs pros and cons – a review.Stud Health Technol Inform 2017; 236: 319-327.
29.
Mehraeen E, Safdari R, SeyedAlinaghi S, Mohammadzadeh N. Exploring and prioritization of mobile-based self-management strategies for HIV care. Infectious Disorders – Drug Targets 2019; 19: 288-296.
30.
Gesesew H, Ward P, Woldemichael K, Mwanri L. Improving the UNAIDS 90-90-90 treatment targets: solutions suggested from a qualitative study of HIV patients, community advocates, health workers and program managers in Jimma, Southwest Ethiopia. Int J Environ Res Public Health 2020; 17: 378.
31.
Maman D, Chilima B, Masiku C, et al. Closer to 90–90–90. The cascade of care after 10 years of ART scale‐up in rural Malawi: a population study. J Int AIDS Soc 2016; 19: 20673.
32.
Mazhnaya A, Marcus R, Bojko MJ, et al. Opioid agonist treatment and improved outcomes at each stage of the HIV treatment cascade in people who inject drugs in Ukraine. J Acquir Immune Defic Syndr 2018; 79: 288-295.
34.
Baesi K, Moallemi S, Farrokhi M, Alinaghi SAS, Truong HHM. Subtype classification of Iranian HIV-1 sequences registered in the HIV databases, 2006-2013. PLoS One 2014; 9: e105098.
35.
Zadeh AOT, SeyedAlinaghi S, Hassanzad FF, et al. Prevalence of HIV infection and the correlates among homeless in Tehran, Iran. Asian Pac J Trop Biomed 2014; 4: 65-68.
36.
d'Arminio Monforte A, Lepri AC, Rezza G, et al. Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naive patients. AIDS 2000; 14: 499-507.
37.
Siika AM, Rotich JK, Simiyu CJ, et al. An electronic medical record system for ambulatory care of HIV-infected patients in Kenya. Int J Med Inform 2005; 74: 345-355.
38.
Ghalehkhani N, Farhoudi B, Gouya MM, et al. The HIV treatment cascade in people living with HIV in Iran in 2014: mixed-method study to measure losses and reasons. Int J STD AIDS 2019; 30: 1257-1264.
39.
SeyedAlinaghi S, Taj L, Mazaheri-Tehrani E, et al. HIV in Iran: onset,responses, and future directions. AIDS 2021; 35: 529-542.
Share
RELATED ARTICLE
| eISSN: | 1732-2707 |
| ISSN: | 1730-1270 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
